Dalan Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3M

  • Investors
  • 12

Dalan General Information

Description

Operator of an insect health company intended to provide sustainable approaches to ensure a safe food supply. The company's platform is based on an oral immunization strategy that helps in the food and feed production supply chain to ensure maximum crop yield without any artificial additives or preservatives, and is suitable for organic agriculture, enabling health professionals to protect the world's honeybees from infectious, deadly diseases and ensure a safe food supply.

Contact Information

Website
www.dalan.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 210 Spring Street
  • Athens, GA 30602
  • United States
+1 (844)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
AgTech, HealthTech
Corporate Office
  • 210 Spring Street
  • Athens, GA 30602
  • United States
+1 (844)

Dalan Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dalan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 02-Dec-2025 $3M Completed Generating Revenue
4. Later Stage VC (Series 1) 31-Oct-2025 Completed Generating Revenue
3. Seed Round 27-Jun-2023 Completed Generating Revenue
2. Seed Round 20-Apr-2021 $1.9M $1.9M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2018 Completed Pre-Clinical Trials
To view Dalan’s complete valuation and funding history, request access »

Dalan Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 2
Seed 1
To view Dalan’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Dalan Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Dalan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4832909-A1 Vaccines for the treatment and prevention of infectious diseases in invertebrates Pending 29-Dec-2023
WO-2025144801-A1 Vaccines for the treatment and prevention of infectious diseases in invertebrates Inactive 29-Dec-2023
AU-2022234422-A1 Vaccine method and composition for bacterial diseases in invertebrates Pending 12-Mar-2021
CA-3210651-A1 Vaccine method and composition for bacterial diseases in invertebrates Pending 12-Mar-2021
EP-4304639-A1 Vaccine method and composition for bacterial diseases in invertebrates Pending 12-Mar-2021 A61K39/09
To view Dalan’s complete patent history, request access »

Dalan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dalan Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Meach Cove Capital Venture Capital Minority
Yuyu Pharma Corporation Minority
Ag Startup Engine Venture Capital Minority
Good Growth Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Dalan FAQs

  • When was Dalan founded?

    Dalan was founded in 2018.

  • Where is Dalan headquartered?

    Dalan is headquartered in Athens, GA.

  • What is the size of Dalan?

    Dalan has 17 total employees.

  • What industry is Dalan in?

    Dalan’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Dalan a private or public company?

    Dalan is a Private company.

  • What is Dalan’s current revenue?

    The current revenue for Dalan is .

  • How much funding has Dalan raised over time?

    Dalan has raised $9.4M.

  • Who are Dalan’s investors?

    European Innovation Council, Meach Cove Capital, Yuyu Pharma, Ag Startup Engine, and Good Growth Capital are 5 of 12 investors who have invested in Dalan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process